Read the Full Article for Free! Read the Full Article for Free! Daily Newsletter Weekly Newsletter (Every Monday) You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access Unlock censored health information that… Read More »
Breadcrumb Trail Links Toronto News Health Canada ‘I do believe that patients with cancer in Canada … are being rendered fatal, terminal or incurable, as a result of what’s happened’ Author of the article: Tom Blackwell Publishing date: Apr 13, 2021 • 8 hours ago • 4 minute read • 84 Comments A doctor exams mammograms,… Read More »
FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 7, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. The… Read More »
Around the time that Dustin Allen, a soft-spoken electrical engineer, turned 27, he noticed a small red spot on his right temple. He thought it was nothing, maybe an acne scar. But it didn’t fade away. In fact, it kept getting darker, and he started to see splotches of dark brown popping up inside it,… Read More »
Delayed cancer screenings amid the pandemic may result in more patients presenting with advanced forms of the disease in the future, doctors worry. “We are certainly worried about the impact of delays in screening and treatment for cancer patients,” Dr. Bob Keenan, chief medical officer of the Florida-based Moffitt Cancer Center, wrote in a statement. Keenan noted the… Read More »
Merck and Eisai were eager to tout a headline phase 3 win in December for their combination therapy of Keytruda and Lenvima because it involves the regimen’s first FDA-approved indication in endometrial cancer. Now we know how big that win is. Keytruda and Lenvima cut the risk of death by 38% over physician’s choice of… Read More »